Human CD47 Protein, His Tag (MALS verified)
分子別名(Synonym)
CD47,MER6,IAP,OA3
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Human CD47, His Tag (CD7-H5227) is expressed from human 293 cells (HEK293). It contains AA Gln 19 - Pro 139 (Accession # Q08722-3).
Predicted N-terminus: Gln 19
蛋白結(jié)構(gòu)(Molecular Characterization)
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 15.6 kDa. The protein migrates as 33-42 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>95% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 24 months in lyophilized state;
-70°C for 12 months under sterile conditions after reconstitution.
背景(Background)
白細(xì)胞表面抗原CD47也被稱為抗原表面決定蛋白OA3、整合素相關(guān)蛋白(IAP)和蛋白MER6。CD47含有1個(gè)Ig樣V型(免疫球蛋白樣)結(jié)構(gòu)域。CD47在正常成人組織中分布非常廣泛。CD47通過充當(dāng)血小板上THBS1的粘附受體在細(xì)胞粘附中發(fā)揮作用,并在整合素的調(diào)節(jié)中發(fā)揮作用。通過相似性,CD47在海馬的記憶形成和突觸可塑性中起著重要作用。CD47是SIRPA的受體,與SIRPA結(jié)合可阻止未成熟樹突狀細(xì)胞的成熟,并抑制成熟樹突狀細(xì)胞產(chǎn)生細(xì)胞因子。CD47與SIRPG的相互作用介導(dǎo)細(xì)胞間粘附,增強(qiáng)超抗原依賴性T細(xì)胞介導(dǎo)的增殖,并共刺激T細(xì)胞活化。
關(guān)鍵字: CD47;CD47蛋白;CD47重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國(guó)生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國(guó)、美國(guó)、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長(zhǎng)期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。